HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer: A Pooled Analysis of Randomized Trials
2007 · JNCI Journal of the National Cancer Institute · 370 citations
https://doi.org/10.1093/jnci/djm252
M
Matteo Puntoni
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
272
Papers
7.3K
Citations
42
h-index
105
i10-index
Matteo Puntoni is an academic researcher from Ospedale di Parma. The author has contributed to research in topics: Metabolism, Diabetes, and Cancer & Estrogen and related hormone effects & Breast Cancer Treatment Studies. The author has an h-index of 42, co-authored 232 publications.
ORCID: 0000-0002-7908-0626Papers by this author
worksHER2/neu Oncoprotein Overexpression in Epithelial Ovarian Cancer: Evaluation of its Prevalence and Prognostic Significance
2005 · Oncology · 137 citations
https://doi.org/10.1159/000086958
The effect of metformin on apoptosis in a breast cancer presurgical trial
2013 · British Journal of Cancer · 78 citations
https://doi.org/10.1038/bjc.2013.657
Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial
2014 · Breast Cancer Research and Treatment · 75 citations
https://doi.org/10.1007/s10549-014-3141-1
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19
2022 · Scientific Data · 72 citations
https://doi.org/10.1038/s41597-022-01534-9
Lapatinib Activity in Premalignant Lesions and HER-2–Positive Cancer of the Breast in a Randomized, Placebo-Controlled Presurgical Trial
2011 · Cancer Prevention Research · 55 citations
https://doi.org/10.1158/1940-6207.capr-10-0337
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat